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Hyporesponsiveness by phagocytes is a well-known
phenomenon in sepsis that is frequently induced
by low-dose endotoxin stimulation of Toll-like recep-
tor 4 (TLR4) but can also be found under sterile in-
flammatory conditions. We now demonstrate that
the endogenous alarmins MRP8 and MRP14 induce
phagocyte hyporesponsiveness via chromatin mod-
ifications in a TLR4-dependent manner that results
in enhanced survival to septic shock in mice. During
sterile inflammation, polytrauma and burn trauma
patients initially present with high serum concentra-
tions of myeloid-related proteins (MRPs). Human
neonatal phagocytes are primed for hyporespon-
siveness by increased peripartal MRP concentra-
tions, which was confirmed in murine neonatal en-
dotoxinemia in wild-type and MRP14/ mice. Our
data therefore indicate that alarmin-triggered phago-
cyte tolerance represents a regulatory mechanism
for the susceptibility of neonates during systemic in-
fections and sterile inflammation.
INTRODUCTION
Activated phagocytes initiate the first line of defense against
infections by sensing pathogen-associated molecular patterns
(PAMPs) through pattern recognition receptors (PRRs), e.g.,
lipopolysaccharide (LPS) by Toll-like receptor 4 (TLR4). During
sepsis, activation of TLRs trigger proinflammatory mechanisms
(Rittirsch et al., 2008). However, dysfunction of TLR signaling2112 Cell Reports 9, 2112–2123, December 24, 2014 ª2014 The Autmay lead to hypoinflammation and immune paralysis, especially
of the phagocyte system. Interestingly, preactivation of TLR4 by
LPS results in transient hyporesponsiveness of phagocytes to
subsequent challenge, known as ‘‘endotoxin tolerance’’ (ET).
This phenomenon is potentially responsible for the immune pa-
ralysis seen in the later course of sepsis, impairing the host’s
ability to combat subsequent bacterial infection.
Hyporesponsiveness of phagocytes under sterile conditions
is a very relevant problem in different clinical conditions where
a remarkable sensitivity to systemic infections is shown. For
example, polytrauma or burn injury patients develop a state of
immune paralysis to secondary infections. In neonates, an
impaired response of the innate immune system has been linked
to the high susceptibility to infection (Wynn et al., 2008). With all
these conditions, an initial microbial trigger is missing, whereas
the adjusted state of immune responsiveness appears to be
critical (Keel et al., 1996). There is now growing evidence that
disseminated inflammation can be modulated by noninfectious
TLR ligands (Cavaillon et al., 2003; Yadavalli et al., 2001). Apart
from PAMPs, endogenous PRR activators, alias damage-asso-
ciated molecular patterns (DAMPs) or alarmins, are released
in response to tissue damage or danger signals and promote
inflammation (Vogl et al., 2012). The phagocyte-specific proteins
myeloid-related protein 8 (MRP8) (S100A8) andMRP14 (S100A9)
are endogenous ligands of the TLR4-CD14-MD2 complex,
amplifying phagocyte activation during sepsis upstream of
tumor necrosis factor alpha (TNF-a)-dependent effects (Vogl
et al., 2007).
We now demonstrate that endogenous MRP8 and MRP14,
similar to exogenous LPS, prime phagocytes for a state of hypo-
responsiveness to subsequent microbial challenge in vitro and in
vivo. Studies were confirmed by comparative bioinformatic ana-
lyses of genome-wide response patterns of human monocyteshors
Table 1. Epidemiologic and Clinical Characteristics of the
Patient Populations
Trauma Burns
n 32 31
Age (years) 46.8 ± 18.7 46.8 ± 20.0
Male (%) 75.0 87.1
ISS 32.3 ± 10.8 N/A
TBSA (%) 0 41.4 ± 15.4
With inhalation injury (%) 0 41.9
ICU (8d) 16.4 ± 16.0 34.0 ± 27.7
Sepsis/MOF (%) 20.1 9.4
Mortality (%) 15.6 29.0
Data are means ± SD or percentages. N/A, not applicable.to tolerizing doses of MRP8-MRP14 or LPS. This MRP-medi-
ated effect depends on aberrations in the nuclear factor (NF)-
kB pathway and methyltransferase G9a-dependent chromatin
modifications.
This mechanism is of clinical relevance in different conditions
of sterile stress and inflammation such as polytrauma and burn
trauma or perinatal susceptibility of newborns to infections.
Our observations reveal that phagocytes can develop a general
‘‘stress tolerance’’ rather than specific ET, which is of potential
relevance for new therapeutic strategies in sterile inflammatory
conditions.
RESULTS
MRP8-MRP14 Serum Levels in Sterile Inflammatory
Conditions
We analyzed the serum concentrations of MRP8-MRP14 in pol-
ytrauma and burn patients (Table 1). We found a biphasic
increase of systemic MRP8-MRP14 level in both polytrauma
(Figure 1A) and burn trauma patients (Figure 1B) with the early
peak at initial presentation representing the innate response to
injury. In burn trauma patients, MRP8-MRP14 concentrations
at the early peak (day 1) significantly correlated with the per-
centage of at least second-degree burned total body surface
area (TBSA) (Pearson’s correlation coefficient 0.47; p % 0.01).
Moreover, survivors showed significantly lower MRP8-MRP14
concentrations than nonsurvivors (Figure 1C). Surprisingly,
when we analyzed the value of MRP8-MRP14 as a marker for
neonatal sepsis, we found that extremely high serum levels
were already detectable in healthy newborns in the first week
of life (Figure 1D). Comparably high levels in adults are only
found in inflammatory diseases (Frosch et al., 2003, 2009; Vie-
mann et al., 2007).
MRP8 and MRP14 Induce Self- and Microbial Tolerance
We analyzed the production of proinflammatory cytokines in
human monocytes prestimulated with different, nonactivating
doses of LPS, MRP8, MRP14, or MRP8-MRP14 (24 hr) prior to
activation with LPS (4 hr). These prestimulations significantly
and dose-dependently attenuated TNF-a release in response
to subsequent LPS restimulation (Figures 2A and 2B). In addi-Cell Retion, the mRNA level of several cytokines as TNF, IL1B, and IL6
were decreased in MRP-pretreated cells after LPS activation
(Figure 2C) whereas other transcripts as formyl peptide receptor
1 (FPR1) or serine/threonine protein kinase (SGK) were increased
(Figure S1A). Moreover, genes that have been shown not to be
sensitive to endotoxin tolerance (Foster et al., 2007) as inhibitor
of DNA binding 3 (ID3) or C-type lectin domain family 4 member
E (CLEC4E) were also insensitive to MRP-induced tolerance
(Figure S1B). Quality of MRP protein preparations was validated
and endotoxin effects excluded by heat-inactivation experi-
ments (Figure S2). Heat-inactivated MRPs failed to induce
tolerance.
Approximately 24 hr after removing the tolerizing stimulus,
monocytes lose their tolerance status and respond to LPS with
adequate TNF-a production (Figure 2D). Pretreatment with
MRP8-MRP14 also induced cross-tolerance to subsequent
bacterial lipoteichoic acid (LTA) or MRP restimulation (Figures
2E–2G). Because all MRP derivatives showed a tolerizing effect,
we focused on the MRP8-MRP14 complex, which represents
the physiologically dominant form (Foell et al., 2007; Roth
et al., 1993; Vogl et al., 2004), in subsequent experiments.
To get an unbiased impression about analogies between
MRP-induced and LPS-induced tolerance, we performed
comparative bioinformatic analyses of genome-wide response
patterns of human monocytes to MRP8-MRP14 and LPS. As-
sessing the variance in gene expression by hierarchical clus-
tering (HC) of the 1,000 most-variable transcripts within the
data set clearly revealed a strong difference between the group
of prestimulated and activated (MRP8-MRP14-LPS and LPS-
LPS) and the prestimulated, but not activated, conditions
(MRP8-MRP14-con and LPS-con; Figure 3A). More importantly
though, there was shown to be no difference in global gene
expression between samples pretreated with either MRP8-
MRP14 or LPS, regardless of activation. Visualizing differen-
tially expressed (DE) genes between prestimulated/activated
and prestimulated/nonactivated monocytes in a ratio/ratio plot
corroborated these findings, placing DE genes on a diagonal
line, which is indicative of high correlation between the two
different pretreatments (Figure 3B). Figure 3C shows exemplary
expression values for candidate genes of both tolerance set-
tings: nontolerized (IL1RN and IL10) or tolerized (TLR4).
High Postnatal MRP8-MRP14 Plasma Levels Attenuate
the LPS Response of Monocytes
The LPS response of human cord blood (CB) monocytes was
significantly impaired compared to adult blood (AB) monocytes
with respect to RNA and protein induction of many proinflamma-
tory genes (Figures 4A and 4B). Preincubation of adult mono-
cytes with CB plasma impaired their LPS response, comparable
to the response of CB monocytes, whereas preincubation with
medium or AB plasma had no effect (Figure 4C). The same
inhibitory effect on proinflammatory gene induction by LPS
was seen in medium transfer experiments with supernatants of
CB monocytes, but not AB monocytes (Figure 4D). Together,
these findings suggest the inhibitory factor in CB plasma as a
specific product of CB monocytes. Subsequently, we excluded
higher basal secretion of proinflammatory cytokines (inter-
leukin-6 [IL-6], TNF-a, and IL-1b) with potentially exhaustingports 9, 2112–2123, December 24, 2014 ª2014 The Authors 2113
Figure 1. MRP8-MRP14 Concentrations in
Sterile Stress and Inflammatory Conditions
(A–C) MRP8-MRP14 levels in (A) polytrauma and
(B) burn trauma patients at initial presentation and
during the later course of disease and (C) at day 1
in survivors (n = 22) and nonsurvivors (n = 9) after
burn injury. Bars represent means ± SD (*p < 0.05).
(D) MRP8-MRP14 levels in healthy term newborn
during the first 3 months of life (n = 98). The dotted
line indicates the mean + two SD of normal adult
MRP8-MRP14 serum levels (n = 80).effects or anti-inflammatory IL-10 by CB monocytes compared
to AB monocytes (Figure 4E). However, the basal secretion of
MRP8-MRP14 was significantly increased in human CB mono-
cytes compared to AB monocytes (Figure 4E). Similar to AB
monocytes (Figure 2D), the LPS response of CB monocytes
recovered after 24 hr if the cells were cultured in medium or
AB plasma, but not in CB plasma or medium spiked with
MRP8-MRP14 (Figure 4F). Inhibition of the proinflammatory
LPS response by CB plasma could almost be completely abro-
gated by either depletion of MRP8-MRP14 from CB plasma
(Figure 4G) or pharmacological inhibition of MRP8-MRP14 using
paquinimod (Figure 4H; Bengtsson et al., 2012). Our data
demonstrate that MRP8-MRP14 in CB plasma is a crucial
endogenous tolerizing factor.
MurineMrp8-Mrp14 InducesMicrobial Tolerance In Vivo
To investigate the biological relevance of these phenomena,
we analyzed Mrp8-Mrp14-induced ET in a model of endotoxic
shock in adult mice (LPS/D-galactosamine [D-Gal] model; Gala-
nos et al., 1979). After intraperitoneal injection of LPS/D-Gal,
nonpretreated mice showed acute symptoms, with most dying
within 5–12 hr. In contrast, mice pretreated with murine Mrp8-
Mrp14 complex showed reduced illness and a significantly
higher survival rate (Figure 5A). The tolerizing effect of Mrp8-
Mrp14 was stronger when mice were pretreated twice instead
of once and comparable to classical LPS-induced ET. In vitro
prestimulation of naive murine bone-marrow-derived macro-
phages (BMDMs) with low doses of LPS and Mrp8-Mrp14
caused no inflammatory response (Figure 5B) but attenuated
the release of Tnf-a upon subsequent LPS (Figure 5C) or LTA
(Figure 5D) restimulation, comparable to the effects seen in hu-
man monocytes. Taken together, these data demonstrate that2114 Cell Reports 9, 2112–2123, December 24, 2014 ª2014 The AuthorsMrp8-Mrp14 induces ET, promoting sur-
vival during LPS/D-Gal-induced septic
shock.
In a second mouse model of neonatal
endotoxemia, we analyzed if the high
postnatal release of Mrp8-Mrp14 induces
LPS tolerance in vivo. First of all, we
confirmed excessive high plasma levels
of Mrps in healthy neonatal mice that,
like in humans, decreased thereafter into
the normal range for adult mice (Fig-
ure 5E). Already 2 hr after LPS injection,
we observed significantly higher in-creases in Tnf-a and Il-6 in Mrp14/ mice compared to wild-
type (WT) mice (Figures 5F and 5G). Due to this overwhelming
inflammation, Mrp14/mice showed significantly lower survival
after LPS challenge, indicating that Mrp8-Mrp14 promotes a hy-
poinflammatory LPS response in neonatal WT mice (Figure 5H).
The Tolerance-Inducing Effect of MRP8-MRP14
Depends on Aberrations in the NF-kB Pathway
In order to analyze the molecular mechanisms underlying the
induction of MRP-induced tolerance, we investigated the upre-
gulation of negative regulators of TLR signaling like interleukin-
1-receptor-associated kinase 1 (IRAK1), suppressor of cytokine
signaling 1 (SOCS1), SOCS3, and tumor necrosis factor alpha-
induced protein 3 (TNFAIP3) by quantitative RT-PCR (qRT-
PCR). We observed an upregulation of IRAK1, SOCS3, and
TNFAIP3 as well as a downregulation of SOCS1 during pretreat-
ment with LPS and MRP (Figure 6A). Because TLR4-dependent
signaling requires p38 mitogen-activated protein kinase (p38
MAPK) activation, we analyzed the phosphorylation of p38
MAPK in prestimulated and LPS-restimulated monocytes (Fig-
ure 6B). We found no difference in p38 MAPK phosphorylation
between naive and pretreated cells during LPS restimulation,
suggesting that p38 MAPK activation is unaltered by LPS or
MRP prestimulation. Accordingly, the tolerant state of MRP-
prestimulated humanmonocytes was also sustained in the pres-
ence of SB202190 inhibitor (Figure 6C).
We went on to analyze the activation of NF-kB, which also
plays an important role in LPS-induced tolerance (Biswas and
Tergaonkar, 2007). Prestimulatedmonocytes differed from naive
monocytes by an increased nuclear translocation of the NF-kB
subunits P65, P50, and RelB upon restimulation with LPS (Fig-
ure 6D). We confirmed the relevance of NF-kB signaling in the
Figure 2. MRP Pretreatment of Monocytes Induces Microbial and Self-Tolerance
(A) TNF-a levels in supernatants of human monocytes after (A) 24 hr pretreatment with medium, LPS, MRP8, MRP14, or MRP8-MRP14 complex (n = 4).
(B) Pretreated cells were activated with LPS (1 ng/ml) for 4 hr, and TNF-a production was analyzed. Data represent mean ± SD and were compared to LPS-
activated control monocytes (n = 4; **p < 0.01; *p < 0.05).
(C) Prestimulated cells were 4 hr activated with LPS (1 ng/ml). mRNA abundance in cells was detected by qRT-PCR. Results are normalized to baseline
expression in control cells, set at 1. Data represent mean ± SD (n = 4).
(D)Monocyteswere left untreated or 24 hr pretreatedwith 10 mg/mlMRP8-MRP14. After medium change and indicated resting times, the cells were 4 hr activated
with LPS (1 ng/ml) and TNF-a production was analyzed. Data represent means + SEM and were compared to data from untreated control cells (n = 6; **p < 0.01;
and *p < 0.05).
(E) Pretreated cells were activated with LTA (1 mg/ml) for 4 hr, and TNF-a production was analyzed. Naive monocytes activated with LTA were used as a positive
control (black bar). Data represent mean ± SD and were compared to LTA-activated naive monocytes (n = 4; **p < 0.01; *p < 0.05).
(F) Pretreated and naive monocytes (black bar) were activated with MRP8 (1 mg/ml) for 4 hr, and TNF-a production was analyzed. Data represent mean ± SD and
were compared to MRP8-activated naive monocytes (n = 4; **p < 0.01).
(G) Pretreated cells and naive monocytes (black bar) were activated with MRP14 (1 mg/ml) for 4 hr, and TNF-a production was analyzed. Data represent mean ±
SD and were compared to MRP14-activated naive monocytes (n = 4; **p < 0.01).
See also Figures S1 and S2.
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Figure 3. Bioinformatic Analysis of Micro-
array Data of MRP- and LPS-Tolerance-
Induced Monocytes
(A) HC of the 1,000 transcripts with the most-sig-
nificant variance in samples from MRP8-MRP14-
con-, MRP8-MRP14-LPS-, LPS-con-, and LPS-
LPS-treated mice.
(B) Ratio/ratio plot for transcripts significantly
differentially expressed between LPS-LPS against
LPS-con and MRP8-MRP14-LPS against LPS-
con (SP; FC > 2; unadjusted p value < 0.05).
(C) Log2 expression values of ILRN, IL10, and
TLR4 determined by DNA microarray analysis.process of MRP-induced tolerance by treating monocytes dur-
ing tolerance induction with the NF-kB inhibitor Bay117085.
Inhibiting NF-kB activation during tolerance induction led to a
substantial increase in TNF-a secretion upon restimulation with
LPS in comparison to nontolerized cells (Figure 6E), indicating
that inhibition of NF-kB activation specifically prevents the in-
duction of MRP-induced tolerance.
MRP-Induced Dimethylation of H3K9 Represses TNF-a
Transcription
RelB has been described to bind and thereby to recruit methyl-
transferase G9a to the TNF-a promoter. G9a in turn dimethylates
histone H3 on lysine K9 (H3K9), resulting in heterochromatin
formation and inaccessibility of the TNF-a promoter to active
transcription factors (Chen et al., 2009). Because MRP presti-
mulation increases nuclear translocation of RelB, we examined2116 Cell Reports 9, 2112–2123, December 24, 2014 ª2014 The Authorsdimethylation of the TNF-a promoter
nucleosome on H3K9 in MRP8-MRP14-
pretreated cells by chromatin-immu-
noprecipitation (ChIP). We observed
increased dimethylation of H3K9 (Fig-
ure 6F) and accordingly increased G9a
activity in LPS- and MRP-pretreated
monocytes compared to controls (Fig-
ure 6G). Inhibition of G9a by BIX01294
during induction of tolerance resulted in
significantly increased TNF-a secretion
in MRP-pretreated cells, but not in LPS-
pretreated cells (Figure 6H), which might
be due to time-dependent differences
in LPS- and MRP-induced tolerance
mechanisms.
In summary, our data indicate that
prestimulation of human monocytes with
MRP8-MRP14 results in an increased,
G9a-dependent H3K9 dimethylation of
the TNF-a promoter responsible for tran-
scriptional silencing of TNF-a expression.
DISCUSSION
It is still an unsolved question how pa-
tients with severe sterile injuries develop
a clinical picture similar to microbial-trig-gered hypoinflammation. In the present study, we demonstrate
that polytrauma and burn trauma patients already had signifi-
cantly elevated levels of the endogenous DAMP proteins
MRP8 and MRP14 at initial presentation. We recently classified
the phagocyte-specific DAMP proteins MRP8 and MRP14 as
two endogenous TLR4 activators (Vogl et al., 2007). MRP8 and
MRP14 are known to form noncovalently associated oligomers
that represent the physiologically relevant form of these proteins
(Roth et al., 1993; Vogl et al., 2004). We now demonstrate that
MRP proteins can induce a state of hypoinflammation in phago-
cytes. Thus, the effect described here resembles classical LPS-
induced tolerance and does not reflect an anti-inflammatory
effect of these proteins as proposed earlier, because the general
effect of these proteins, like for LPS, is a proinflammatory func-
tion in many inflammatory conditions. We found wide cross-
tolerance between pre-/restimulation of different microbial TLR
activators and endogenous triggers like MRP8 and MRP14.
Interestingly, it has been shown earlier that different PAMPs
can substitute for each other, inducing cross-tolerance between
the TLR2 and TLR4 pathways (Akira and Takeda, 2004). Our pre-
sent data point to a general mechanism of stress-induced rather
than specific microbial tolerance, in which exogenous and
endogenous triggers of infection and injury not only amplify in-
flammatory reactions but also act in concert in a negative feed-
back loop, preventing overwhelming inflammation and tissue
damage. Uncontrolled release of these proteins, on the other
hand, may result in severe dysregulation of inflammatory func-
tions like immune paralysis in polytrauma and burn trauma pa-
tients. The biological relevance of this phenomenon is confirmed
by the fact that pretreatment with Mrp8-Mrp14 complex signifi-
cantly protects mice against LPS-induced shock similar to clas-
sically induced LPS tolerance (Melo et al., 2010).
Whereas undefined endogenous triggers of inflammation have
been presumed for the pathogenesis of trauma and burn
patients, our data significantly challenge current paradigms
regarding the high susceptibility of neonates to infections, which
still remains a leading causeofmortality (Kilbride et al., 2003; Stoll
et al., 1996, 1998, 2002). The primary LPS response of neonatal
monocytes is characterized by strong suppression of the induc-
tion of proinflammatory mediators compared to adult mono-
cytes, suggesting innate resistance to infectious triggers. During
the postpartum period, human and murine neonates present
with significantly increased serum levels of MRP8-MRP14 com-
parable to those in adults with severe inflammatory processes.
In adult monocytes tolerized by MRP8-MRP14 pretreatment,
we found a recovery of LPS responsiveness after about 24 hr.
Accordingly, after culturing neonatal monocytes in MRP8-
MRP14-free medium, we found a recovery of the neonatal LPS
responsewithin a similar time frame of 24 hr. Transfer of neonatal
plasma to adult monocytes mimicked the ET-inducing effects of
purified MRP8-MRP14, which could be abrogated by depletion
of MRP8-MRP14 from the plasma or pharmacological inhibition
of MRP8-MRP14 by paquinimod (Bengtsson et al., 2012). In
addition, LPS-induced systemic inflammation in neonates of
WT and Mrp14/ mice confirmed the biological relevance of
our findings in vivo. Taken together, these data point to a
molecular mechanism underlying the susceptibility of neonates
to infections in which peripartal stress-triggered release of an
endogenous TLR4 stimulus induces a state of hypoinflammation
in neonatal phagocytes. Whether the hypoinflammatory state
of neonatal phagocytes is disadvantageous, promoting the sus-
ceptibility of neonates to infections, or whether it is beneficial in
preventing infection-induced courses of endotoxic shock needs
to be clarified in follow-up studies.
We demonstrate that intracellular expression and cell surface
exposition of TLR4 and TLR2 were unaltered by MRP8-MRP14
or LPS-mediated tolerance induction (data not shown), indi-
cating that common TLR4- and TLR2-signaling pathways must
be differentially regulated in tolerized and naive monocytes
downstream of the receptor level. The ‘‘Myd88-dependent’’
pathway triggers the activation of downstream kinases such as
MAPK and ultimately results in translocation of NF-kB to the nu-
cleus, initiating transcription of inflammatory cytokines (Biswas
and Tergaonkar, 2007). We present evidence that severalCell Reregulatory factors in the MyD88-dependent signaling cascade
that have been described as playing a role in ET, like IRAK1,
SOCS3, or TNFAIP3, are significantly downregulated in MRP
prestimulated monocytes comparable to LPS, indicating that
similar inhibitory mechanisms dominate the signaling cas-
cades downstream of TLR in ‘‘tolerized’’ phagocytes indepen-
dent of the initial stimulus. Moreover, bioinformatic analysis of
genome-wide transcriptomes of MRP8-MRP14- and LPS-pres-
timulated human monocytes revealed that MRP and LPS presti-
mulation induces an almost identical response pattern in human
monocytes.
MAPK p38 is one of the intracellular downstream signaling
components common to both TLR4 and TLR2, playing an essen-
tial role in the induction of proinflammatory cytokines (Zarubin
and Han, 2005). However, we observed a similar increase in
p38 phosphorylation in both control and MRP8-MRP14-pre-
treated cells after restimulation with LPS, suggesting that p38
activation is unaltered by MRP8-MRP14 prestimulation. In addi-
tion, the tolerant state of MRP8-MRP14-prestimulated cells was
sustained in the presence of the p38 inhibitor SB202190, indi-
cating that p38 MAPK activation is not relevant for MRP8-
MRP14-induced microbial tolerance.
Several studies have demonstrated impaired NF-kB activity
in endotoxin-tolerant murine macrophages and human mono-
cytes. Thus, monocytes from sepsis as well as trauma patients
have been described as overexpressing transcriptionally inac-
tive dimers of p50 or p65/RelB (Cavaillon et al., 2003; Ziegler-
Heitbrock, 2001). In our experiments, prestimulation of
monocytes with LPS or MRP8-MRP14 led to increased nuclear
translocation of p50, p65, and RelB proteins. Moreover, we
demonstrated that inhibition of NF-kB activation almost com-
pletely prevents the induction of ET, which is reflected by
increased TNF-a production in ‘‘tolerance-induced’’ monocytes.
Therefore, our data suggest that NF-kB seems to have an impor-
tant function within the TLR4-dependent signaling cascade of
MRP8-MRP14- and LPS-tolerant monocytes.
Aside from directly modulating the transactivation of target
genes by affecting the binding of NF-kB to its binding sites,
epigenetic modifications such as histone and DNA methylation
have an important role in selective gene expression in LPS toler-
ance (El Gazzar et al., 2008; Foster et al., 2007). Interestingly,
previous studies analyzing LPS-induced ET reported recruitment
of RelB to the TNF-a promoter, where it directly binds to methyl-
transferase G9a. G9a in turn dimethylates histone H3 on lysine
K9, resulting in heterochromatin formation and promoter inac-
cessibility for transcriptionally active transcription factors (El
Gazzar et al., 2008). Consistent with these reports, we observed
increased histone methyltransferase G9a activity and dimethyla-
tion of the TNF-a promoter nucleosome on H3K9 in MRP8-
MRP14-pretreated monocytes. Accordingly, inhibition of G9a
activity abolished MRP8-MRP14-induced tolerance. In conclu-
sion, we demonstrate that MRP8-MRP14, an endogenous ligand
of TLR4, inducesmicrobial and self-tolerance. Interestingly, con-
centration levels of these proteins found in the early ‘‘vulnerable’’
phase of sterile inflammation in polytrauma and burn patients
point to a clinical relevance of this pathomechanism. Moreover,
high peripartal MRP8-MRP14 serum levels seem to be mainly
responsible for a hypoinflammatory state in neonatal monocytes,ports 9, 2112–2123, December 24, 2014 ª2014 The Authors 2117
Figure 4. Impaired LPS Responses of Neonatal Monocytes Are Mediated by High Postnatal MRP8-MRP14 Plasma Levels
(A) Human monocytes were isolated from AB (dark gray bars; n = 12) or CB (light gray bars; n = 11) and 4 hr stimulated with LPS. Changes in inflammatory gene
expression compared to untreated control cells were analyzed by qRT-PCR and plotted as fold change (FC).
(B) Human monocytes isolated from AB (n = 9) and CB (n = 9) were 16 hr treated with LPS (gray bars) or left untreated (black bars) and IL-6 and TNF-a levels
determined in supernatants. Bars represent means ± SD (*p < 0.05).
(legend continued on next page)
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supporting the hypothesis that soluble factors released during
delivery and not inborn functional deficits of immune cells deter-
mine the responsiveness of neonatal innate immune cells upon
microbial challenges.
EXPERIMENTAL PROCEDURES
Patients and Study Design
The study comprised 32 polytrauma and 31 burn trauma patients (Department
of Surgery of Munich University Hospital). Exclusion criteria were age < 18
years, hospital admission later than 6 hr after injury, severe preexisting
infections, and immunologic or cardiovascular diseases requiring long-term
medication. Healthy blood donors (n = 61; 51% male) served as controls. All
patients received surgical care and intensive care unit (ICU) treatment. Injury
severity scores (ISS) were calculated based on the final patient records
(Greenspan et al., 1985). Injury severity in burns was assessed by the percent-
age of TBSA. Severe sepsis and multiple organ failure (MOF) were diagnosed
as described earlier (Bone et al., 1992; Majetschak et al., 2008). Sepsis and
MOF were combined as sepsis/MOF positive or negative because MOF
without positive criteria of severe sepsis or septic shock after polytrauma
and burns was expected to be rare. Duration of ICU treatment was docu-
mented based on the final patient records.
For the analysis of MRP8-MRP14 serum levels in healthy term neonates, we
enrolled 98 neonates (gestational ageR 37 weeks). Blood was taken on days
1–84 of life for the national screening program for inborn errors of metabolism
or for routine blood tests without underlying inflammatory diseases. Normal
adult MRP8-MRP14 serum values were determined in blood samples from
80 healthy AB donors.
Reagents and Antibodies
LPS (Escherichia coli 055:B5), D-Gal, actinomycin D, and polymyxin B were
purchased from Sigma. LTA from Staphylococcus aureus was obtained from
InvivoGen. Paquinimod (ABR-215757) was a kind gift of Active Biotech AB.
BIX01294 and Bay117085 were purchased from Enzo Life Sciences and
SB202190 from Merck. The p38 (9212), phospho-p38 (9211), and RelB
(4954) antibodies were obtained from Cell Signaling. P50 (ab7971), P65
(ab7970), and anti-HA tag (ab9110) antibodies were purchased from Abcam.
A lamin B (C-20) antibody was purchased from Santa Cruz Biotechnology,
and MRP8 (8-5C2) and MRP14 (S32-2) antibodies were obtained from BMA.
Monoclonal anti-human MRP8-MRP14 (clone 27E10), polyclonal anti-human
MRP8, and polyclonal anti-human MRP14 antibodies were purified by T.V.
Purification of MRP8 and MRP14 Derivatives
The human MRP8-MRP14 heterodimer was isolated from granulocytes as
described earlier (van den Bos et al., 1998). MRP8, MRP14, Mrp8, Mrp14,
and Mrp8-Mrp14 were recombinantly expressed in E. coli BL21(DE3) and
purified as described earlier (Vogl et al., 2006). Proteins were analyzed by
amino acid sequencing and electrospray ionization mass spectrometry. All(C) HumanABmonocyteswere 16 hr cultured inmedium (black bars), AB plasma (d
respectively). Induction of TNF expression was analyzed by qRT-PCR and plotte
(D) Human AB monocytes 24 hr preincubated with medium (black bars) or with su
bars) were treated with LPS (n = 4) and expression of IL1B, TNF, and IL6 analyze
(E) Supernatants from human AB (dark gray bars; n = 4) and CB monocytes (light
MRP14 and indicated cytokines. Bars represent means ± SD; *p < 0.05.
(F) Human CBmonocytes were cultured in medium (black bars), CB plasma (light
or AB plasma (dark gray bars) for 16 hr and 24 hr before stimulation with LPS (n =
plotted as mean ± SD (*p < 0.05; **p < 0.01).
(G) Human CB monocytes were cultured for 24 hr in medium (black bars), AB pl
plasma (dotted gray bars), or control-precipitated CB plasma (gray bars). Afterw
analyzed by qRT-PCR (mean ± SD; n = 4; *p < 0.05; **p < 0.01). Efficiency of MRP
representative western blot.
(H) Human CBmonocytes were cultured for 24 hr in medium, CB plasma, or mediu
500 ng/ml (dark gray bars) or 1 mg/ml (gray bars) paquinimod. Afterward, they we
qRT-PCR and plotted as mean ± SD (n = 4; *p < 0.05; **p < 0.01).
Cell Repreparations revealed >98% purity. Endotoxin contaminations were excluded
by limulus amebocyte lysate assay (BioWhitaker), heat inactivation (30 min at
80C), and polymyxin-B-blocking experiments.
Cells and Cell Culture Conditions
Human adult monocytes were isolated from buffy coats and neonatal mono-
cytes from CB by Ficoll-Paque density gradient centrifugation and by using
the Monocyte Isolation Kit II (Miltenyi Biotec). The purity of the isolated mono-
cytes was >90% and checked by flow cytometry using phycoerythrin-labeled
anti-CD14 monoclonal antibody (BD Biosciences). Cells were cultivated as
previously described (Roth et al., 1993). For experiments with AB or CB
plasma, monocyte medium was used 1:1 with plasma. For MRP8-MRP14 in-
hibition experiments, paquinimod was added in indicated concentrations. In
medium transfer experiments, supernatant from 24 hr cultured AB or CB
monocytes was used 1:1 with medium for preincubation. BMDMs were
flushed from femurs and tibias and cultured in Dulbecco medium for 6 days
as described earlier (Vogl et al., 2007). For tolerization, 1 3 106 cells/ml were
24 hr incubated with varying concentrations of LPS (0.025–1,000 ng/ml),
MRP8 or MRP14 (50–250 ng/ml), or MRP8-MRP14 (0.5–10 mg/ml). Subse-
quently, cells were stimulated with LPS (1 ng/ml); LTA (1,000 ng/ml), or
MRP8 and MRP14 (1,000 ng/ml) for different times.
IP of MRP8-MRP14
For the removal of MRP8-MRP14, CB plasma was precleared two times with
protein A/G agarose beads (Pierce/Thermo Scientific). Then, CB plasma was
incubated overnight with beads coupled with 27E10 (MRP-immunoprecipita-
tion [IP]) or anti-HA tag antibody (control-IP). Probes from CB plasma before
and after MRP-IP and control-IP as well as from the precipitates were retained
for cell culture experiments and immunoblotting against MRP8 and MRP14.
Gene Array Expression Studies and Bioinformatic Analyses
Total RNA of human monocytes was isolated (NucleoSpin RNA II kit; Ma-
cherey-Nagel) and used for analysis by Illumina human HT-12 Expression
BeadChips. The protocol was performed according to the manufacturer’s in-
struction (Illumina). Data were imported into Partek Genomics Suite 6.6 (PGS,
version 6.14.0724) using robust multiarray average algorithm prior to batch
correction. A one-way ANOVAmodel was performed to calculate the differen-
tially expressed genes between the different stimulating conditions and
the 1,000 most-variable genes. Differentially expressed genes were defined
by a fold change (FC) >2 or <2 and a false discovery rate (FDR)-corrected
p < 0.05. To visualize the structure within the data, we performed HC
on the 1,000 most-variable genes, with default settings in PGS, on FDR-cor-
rected values according to the expression values of the samples across the
conditions. In addition, we calculated the ratios between LPS-LPS against
LPS-con and MRP8-MRP14-LPS against LPS-con to compare the influence
of pretreatment with either MRP8-MRP14 or LPS.
Nuclear Cell Extracts
Nuclear cell extracts were prepared using an extraction kit (Epigentek).ark gray bars), or CBplasma (light gray bars) before stimulationwith LPS (n = 3,
d as mean ± SD (*p < 0.05).
pernatant from 24 hr cultured AB (dark gray bars) or CB monocytes (light gray
d by qRT-PCR. Plotted are means ± SD (*p < 0.05; **p < 0.01).
gray bars; n = 6) were analyzed after 24 hr for basal secretion levels of MRP8-
gray bars), medium spiked with 2 mg/ml MRP8-MRP14 (medium +, white bars),
4, respectively). Induction of TNF expression was analyzed by qRT-PCR and
asma (dark gray bars), CB plasma (gray bars), MRP8-MRP14-precipitated CB
ard, they were stimulated for 4 hr with LPS and induction of TNF expression
8-MRP14 removal was determined by western blot analysis. Results show one
m spiked with 5 mg/ml MRP8-MRP14 without (black bars) or in the presence of
re stimulated for 4 hr with LPS. Induction of TNF expression was analyzed by
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Figure 5. MRP8-MRP14 Induces Microbial
Tolerance in Murine Model Systems
(A) WT mice were treated with LPS/D-Gal without
pretreatment (n = 18) or after a single- or double-
intravenous application (24 hr or 24 hr plus 12 hr
before LPS/D-Gal treatment) of Mrp8-Mrp14
complex (300 mg per mouse; n = 18; three inde-
pendent experiments) or LPS (100 ng per mouse;
24 hr before LPS/D-Gal treatment; n = 18). The
figure shows the percentage of survivors over
48 hr (*p < 0.05; ***p < 0.001).
(B–D) Analysis of Tnf-a in supernatants of WT
BMDMs. (B) Cells were 24 hr pretreated with
substimulating doses of LPS (10 ng/ml), Mrp8-
Mrp14 complex (10 mg/ml), or left untreated and
(C) subsequently 4 hr restimulated with LPS (1 mg/
ml) or (D) LTA (1 mg/ml). Data represent mean ± SD
and were compared to data from LPS/LTA-acti-
vated naive BMDMs (black bar; n = 3; **p < 0.01).
(E–H) Postnatal release of Mrp8-Mrp14 induces
LPS tolerance in vivo. (E) Plasma levels of Mrp8-
Mrp14 complex in neonatal WT mice on day 1 and
2 of life (n = 10, respectively) and in adult WT mice
(white bar; n = 6) plotted as mean ± SD. (F and G)
After treatment of neonatal WT mice (gray bars)
and Mrp14/ mice (black bars) for 2 hr with PBS
(control; C) or LPS, RNA was isolated from
neonatal liver lysates and plasma samples were
obtained (n = 4, respectively). (F) mRNA expres-
sion of Tnf and Il6 were analyzed in relation to
Gapdh, and (G) plasma cytokine levels of Tnf-a
and Il-6 were determined. Results are plotted as
mean ± SD, respectively (*p < 0.05; **p < 0.01). (H)
Neonatal WT (n = 22) and Mrp14/ (n = 27) mice
were treated with 10 mg LPS. Kaplan-Meier sur-
vival curves show the percentage of survivingmice
over 80 hr.Determination of TNF-a, IL-6, IL10, IL-1b, and MRP8-MRP14
Concentrations
TNF-a/Tnf-a release was determined in supernatants of human monocytes or
BMDMs by commercial ELISAs (BDBioscience). In addition, concentrations of
TNF-a/Tnf-a, IL-6/Il-6, IL-10, and IL-1b were determined using the human
inflammation cytometric bead array or mouse FlexSet (both BD Bioscience).
Serum/plasma concentrations of human/murine MRP8-MRP14 were deter-
mined by ELISA as described previously (Frosch et al., 2000). TNF-a and
IL-6 analyses were performed after 4 hr of activation and IL-10 and IL1-b
analysis after 16 hr of culture time.
qRT-PCR
RNA was isolated using the Nucleospin isolation kit II. qRT-PCR was per-
formed as described earlier (Viemann et al., 2006). Sample data are presented
as fold induction compared to control cells.2120 Cell Reports 9, 2112–2123, December 24, 2014 ª2014 The AuthorsMice
C57BL/6 mice (WT; Harlan Laboratories) and
Mrp14 knockout mice (/; Manitz et al., 2003)
were used and housed pathogen free.
LPS-Induced Septic Shock in the D-Gal
Model
Septic shock was induced in 2-month-old WT
mice by intraperitoneal injection of 40 mg
LPS and 680 mg D-Gal per kg body weight,
respectively. In parallel, mice were pretreatedby intravenous injection of 100 ng LPS or 300 mg Mrp8-Mrp14 per
mouse, followed by a LPS/D-Gal challenge 24 hr later. In additional
approaches, Mrp8-Mrp14 complex was injected twice (12 hr and 24 hr)
before LPS/D-Gal challenge. The survival of challenged mice was analyzed
for 48 hr.
Mouse Model of Neonatal Endotoxemia
Neonatal WT and Mrp14/ mice were used at the age of 2 days. Pups were
subcutaneously injected with 10 mg LPS or PBS (control). For cytokine expres-
sion analysis, blood and organs were harvested 2 hr after LPS treatment. For
survival studies, mice were observed for 80 hr.
ChIP Assays
Cells (13 107 per condition) were fixed with 1% formaldehyde and lysed in 1%
SDS for 10 min. The DNA was sheared by sonification and an aliquot kept as
Figure 6. TLR Signaling in Tolerance-Induced Monocytes
(A) qRT-PCR analysis of SOCS1, SOCS3, IRAK1, and TNFAIP3 expression in human monocytes stimulated for 24 hr with LPS (25 pg/ml), MRP8-MRP14 (10 mg/
ml), or MRP8 (100 ng/ml). Results are presented relative to baseline expression in naive cells (black bar), set as one normalized toGAPDH. Data represent mean ±
SD (n = 4; *p < 0.05).
(B) Monocytes were left untreated or 24 hr tolerized with LPS (25 pg/ml) or MRP8-MRP14 (10 mg/ml). After 30 min LPS activation, p38 phosphorylation was
determined by western blot analysis. One representative western blot and densitometric analysis of three independent experiments are shown. p38 phos-
phorylation in restimulated naive cells (control) was set at 100%.
(legend continued on next page)
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input control. The DNA-protein complexes were precipitated with polyclonal
anti-dimethyl-histone H3 (Lys9) antibody or immunoglobulin G (both Millipore)
and extracted with protein A/G-agarose beads. After intensive washing,
the samples were overnight incubated at 65C and proteins digested with pro-
teinase K. DNA was purified and amplified using TNF promoter primers (F:
AACCGAGACAGAAGGTGCAGG; R: AGAATCATTCAACCAGCGGAAA). PCR
products were run on a 1.5% agarose gel, quantified with ImageJ software,
and normalized to control cells.
G9a Activity Assay
G9a activity was measured according to the manufacturer’s instructions
(EpiQuik Histone Methyltransferase Activity/Inhibition Assay Kit; Epigentek).
Samples were normalized to control cells.
Statistical Analysis
Statistical significance was calculated using the Mann-Whitney U test or
paired Student’s t test. p values < 0.05 were judged to be significant.
Kaplan-Meier survival curves were generated using the Mantel-Cox test.
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